Supplemental Figure 9 from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors
Howard L. Li, Soren Charmsaz, Chester Kao, Carlotta Pazzi et autres
0 citations
Mari Nakazawa
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
151Publications signalées
4384Citations signalées
4Affiliations récentes
Institutions déclarées
Domaines associés
Colorectal Cancer Treatments and StudiesLung Cancer Treatments and MutationsGastric Cancer Management and OutcomesCancer Immunotherapy and BiomarkersProstate Cancer Treatment and Research
Publications récentes
Supplemental Table 6 from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors
Howard L. Li, Soren Charmsaz, Chester Kao, Carlotta Pazzi et autres
0 citations
Supplemental Figure 13 from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors
Howard L. Li, Soren Charmsaz, Chester Kao, Carlotta Pazzi et autres
0 citations
Supplemental Table 2 from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors
Howard L. Li, Soren Charmsaz, Chester Kao, Carlotta Pazzi et autres
0 citations
Supplemental Figure 4 from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors
Howard L. Li, Soren Charmsaz, Chester Kao, Carlotta Pazzi et autres
0 citations
Supplemental Figure 15 from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors
Howard L. Li, Soren Charmsaz, Chester Kao, Carlotta Pazzi et autres
0 citations
Supplemental Figure 7 from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors
Howard L. Li, Soren Charmsaz, Chester Kao, Carlotta Pazzi et autres
0 citations
Supplemental Figure 3 from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors
Howard L. Li, Soren Charmsaz, Chester Kao, Carlotta Pazzi et autres
0 citations
Data from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors
Howard L. Li, Soren Charmsaz, Chester Kao, Carlotta Pazzi et autres
0 citations
Supplemental Figure 10 from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors
Howard L. Li, Soren Charmsaz, Chester Kao, Carlotta Pazzi et autres
0 citations
Supplemental Table 1 from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors
Howard L. Li, Soren Charmsaz, Chester Kao, Carlotta Pazzi et autres
0 citations
Supplemental Table 4 from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors
Howard L. Li, Soren Charmsaz, Chester Kao, Carlotta Pazzi et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.